Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Clinton: Women ‘expect’ extremism from terrorists, not GOP candidates
- People who knew Virginia TV station shooter Flanagan recall his quick temper
- Obama marks Hurricane Katrina anniversary in New Orleans visit
- Planned Parenthood alleges ‘smear’ campaign in letter to top lawmakers
- Compatibility of 1st-responder radios in doubt
- Ex-crime lab chief: Illegal’s fatal shot in San Francisco likely accidental
- 13 states spared EPA regulation of waterways
- Bison gores worker on California’s Catalina Island
- US economy surged at 3.7 percent rate in April-June quarter
- Virginia reporter, cameraman killed on air; gunman also dies
- Pentagon probes ISIS assessment